Understanding Cannabinoid Research
As legal access to cannabis and hemp expands, so does the ability to research its many active compounds. Modern science is finally starting to gain the resources, tools, and permission to validate the therapeutic benefits that people have long experienced, and explore the next frontier of applications.
But as research starts to surface, it can be hard to bridge complex scientific findings with real life implications. How can we go beyond headlines, to understand the bigger picture of cannabinoid research and navigate what are credible advances vs hype and buzz?
In this session, we will be speaking to cannabinoid therapy educator and expert, Mary Brown, who has spent over a decade working at the intersection of clinical cannabinoid research and patient responses to cannabinoid-based medicines.
- Types of existing cannabinoid research
- What to make of recently published OSU findings
- Cutting through the buzz
Co-Founder of Polite & Revida Labs
Founder, SMJ Consulting at the AIMS Institute
Society of Cannabis Clinicians
Mary Brown brings over a decade of experience in the clinical application of cannabinoid therapy to her role as CCO of Polite. She studies trends in data and patient responses to help guide medical professionals and patients towards developing a greater understanding of the beneficial impacts of purposeful cannabinoid therapy dosing protocols. As founder of SMJ Consulting, she has focused on sharing her expertise through individual and group cannabis health education, as well as acting in an advisory role to businesses and global governments on medicinal cannabis. Mary is strongly invested in researching the impact of cannabinoids on pediatric cancer patients and believes deeply in advocating for the rights of patients of all ages to secure natural medicinal options. She has co-authored a chapter on cannabinoids in the 5th edition of the Palliative Care and Supportive Oncology medical textbook.
Jessica has been involved in the guidance and education of cannabinoid therapy to patients for over 6 years, while also developing protocols and formulas based on data trends gathered from patients' therapeutic cannabinoid responses. Jessica has applied her expertise and knowledge of the Endocannabinoid System to the new publication of the 5th edition of Palliative Care and Supportive Oncology medical textbook. She also helped coordinate a Harvard study of cannabis and its effects on cognitive ability and recovery. She is currently teaching the Pulmonary Dynamics of Vaporizing Vs. Smoking course through the Academy of Cannabis Science in 3 different college programs.
